Covea Finance Gilead Sciences, Inc. Transaction History

Covea Finance

$2.2 Billion
Q1 2025

A detailed history of Covea Finance transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Covea Finance holds 30,500 shares of GILD stock, worth $3.33 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

30,500

Holding current value

$3.33 Million

% of portfolio

0.16%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 22, 2025	BUY	$89.14 - $117.41 $2.72 Million - $3.58 Million	30,500 New	30,500 $3.42 Million

Others Institutions Holding GILD

# of Institutions

2,285

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

Black Rock Inc. New York, NY

121M
Shares

$13.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

117M
Shares

$12.8 Billion
0.25% of portfolio
State Street Corp Boston, MA

59.5M
Shares

$6.49 Billion
0.28% of portfolio
Capital Research Global Investors Los Angeles, CA

54.6M
Shares

$5.96 Billion
1.39% of portfolio
Capital World Investors Los Angeles, CA

53.5M
Shares

$5.84 Billion
1.01% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $137B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covea Finance, based on Form 13F filings with the SEC.

News

Stay updated on Covea Finance with notifications on news.

Account